A 71-year-old woman with non-operable, peripheral type chronic thrombo-embolic pulmonary hypertension (CTEPH) and with World Health Organisation (WHO) class III dyspnoea was admitted to our department for balloon pulmonary angioplasty (BPA). Right heart catheterisation confirmed pulmonary hypertension (mean pulmonary artery pressure (mPAP) 37 mm Hg, mean right atrial pressure (mRAP) 6 mm Hg, pulmonary capillary wedge pressure (PCWP) 13 mm Hg, pulmonary vascular resistance (PVR) 214 dyn · s · cm -5 and cardiac Index (CI) 4
A 71-year-old woman with non-operable, peripheral type chronic thrombo-embolic pulmonary hypertension (CTEPH) and with World Health Organisation (WHO) class III dyspnoea was admitted to our department for balloon pulmonary angioplasty (BPA). Right heart catheterisation confirmed pulmonary hypertension (mean pulmonary artery pressure (mPAP) 37 mm Hg, mean right atrial pressure (mRAP) 6 mm Hg, pulmonary capillary wedge pressure (PCWP) 13 mm Hg, pulmonary vascular resistance (PVR) 214 dyn · s · cm -5 and cardiac Index (CI) 4.1 l/min · m 2 ) and pulmonary scintigraphy showed multiple segmental perfusion defects (segments 1, 2, 8, 9 in the left lung and 2, 3, 4, 5, 6 in the right lung). Functional testing demonstrated a reduced 6-minute walk distance of 220 m. The BPA was performed from a right femoral vein approach. The 90-cm long 6Fr sheath (Flexor Shuttle Guiding Sheath, Cook Medical, Bloomington, IN, USA) and right Judkins 6-Fr guide catheter were used to achieve a good approach to the ostium of the A1 + A2 segmental branch. Selective pulmonary angiography revealed the subtotally occluded A1 segmental branch of the left pulmonary artery (Figure 1 A) . Subsequently a Whisper MS coronary guidewire (Abbott Vascular, Santa Clara, Ca, USA) was advanced through the lesion to the distal part of the vessel. Then optical coherence tomography (OCT) of the target vessel was performed with the DragonFly (St. Jude Medical, USA) OCT catheter. Iodinated contrast was infused at a flow rate of 5 ml/s over 4 s at 400 psi of pressure and OCT images were acquired. Subsequently the vessel was accurately measured in several locations and the proper size of the balloon was selected to reduce the risk of post-reperfusion oedema.
Surprisingly, OCT revealed extensive changes in the proximal and mid part of the target artery ("colander lesions" or meshwork) (Figure 1 B) . The diameter of the vessel was 2.23 mm × 2.42 mm. Four inflations of a 2.0 mm × 20 mm semi-compliant balloon with the pressure of 4-10 atm were performed along the entire artery with good angiographic and hemodynamic effects (Figure 1 C) . The procedure was uneventful. Three more BPA sessions at intervals of a few weeks were performed and mPAP was reduced to 29 mm Hg (mRAP -7 mm Hg, PCWP -13 mm Hg, PVR -167 dyn · s · cm -5 , CI -4.1 l/min · m 2 ) and 6-minute walking test (6-MWT) increased to 430 m. The BPA is an emerging method of treatment of patients with inoperable CTEPH [1, 2] . The use of intra-vessel imaging (intra-vessel ultrasound -IVUS) during BPA procedures has been shown to reduce complication frequency. The OCT offers better spatial image resolution (10-20 μm, which is tenfold higher than obtained with IVUS), higher reproducibility and lower interand intraobserver variability [3] . The OCT allows one to determine the location, extent and character of the pulmonary artery lesions and helps to choose the appropriate balloon size and length [4, 5] . However, it requires a high-pressure contrast injection, and the clearance of the pulmonary vessel might be insufficient in some cases, which may limit the usefulness of this technique in some cases.
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